Cue health hasn’t officially disclosed its ipo date yet, but several reports indicate that it could come as early as sep. 1d 5d 1m 3m 6m ytd 1y 3y all range dropdown.
If you are looking for stocks with good return, cue health inc can be a profitable investment option.
Cue health stock price prediction. The cue health stock forecast is 57.610151561346 usd for 2022 november 27, sunday; Cue health inc (hlth) forecast based on technical analysis. Hlth stock cue health inc.
Cue biopharma stock price prediction is an act of determining the future value of cue biopharma shares using few different conventional methods such as eps estimation, analyst consensus, or fundamental intrinsic valuation.the successful prediction of cue biopharma's future price could yield a significant profit. Revenue was $223.7 million for the third quarter of 2021, compared to $137.4 million for the prior quarter and $4.7 million for the prior year. Hlth), a health technology company, today announced the pricing of its initial public offering of 12,500,000 shares of its common stock at a public offering price of $16.00 per share, for gross proceeds of $200.0 million, before deducting underwriting discounts and commissions.
Summary of all time highs, changes and price drops for cue health; Hlth stock cue health inc. The price and eps surprise chart displays the company's stock price along with the eps surprise.
The company was formerly known as cue inc and changed its name to cue health inc. How high can cue health (hlth) stock go? Since then, cue stock has decreased by 23.6% and is now trading at $12.01.
Hlth), a health technology company, today announced the pricing of its initial public offering of 12,500,000 shares of its common stock at a public offering price of $16.00 per share, for gross proceeds of $200.00 million, before deducting underwriting discounts and. Based on 1 technical indicators where 0.00% are on buy, 0.00% on sell, and 100.00% neutral. The san diego biotech estimates that its initial public offering of common stock will be priced in range of $15 to $17 per share with a proposed maximum aggregate offering price of $244 million.
The company was incorporated in 2010 and is headquartered in san diego, california. It spent the better part of a decade as a diagnostic testing. Today we'll share whether or not to buy cue health ipo shares.
Cue health's common stock is expected to begin trading on the nasdaq global select market on september 24, 2021 under the ticker symbol hlth. the offering is expected to close on september 28. The average cue health stock price prediction forecasts a potential downside of n/a from the current hlth share price of $11.46. According to the issued ratings of 3 analysts in the last year, the consensus rating for cue biopharma stock is buy based on the current 3 buy ratings for cue.
According to the market data, cue health inc (hlth) stock price is $13.14 and the 52 weeks low is $0, which means the cue health inc stock price is returning to its initial position. Learn more on cue's analyst rating history And 284.891 usd for 2026 november 27, friday.
Third quarter 2021 financial results. Hlth) forecast roe is n/a, which is considered weak. The stock is expected to trade in a range between $15 and $17.
That does not necessarily mean it's a buy, though. That values cue health at $2.9 billion. 9.65 52 week range 18.42.
Cue health (hlth) stock price prediction is 57.610151561346 usd. Eps surprise is the difference (expressed as a percentage) between the actual reported quarterly.
0 komentar:
Posting Komentar